Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 453 SEK 0.11% Market Closed
Market Cap: 14.3B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Wall Street
Price Targets

XVIVO Price Targets Summary
Xvivo Perfusion AB

Wall Street analysts forecast XVIVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XVIVO is 555.7 SEK with a low forecast of 484.8 SEK and a high forecast of 613.2 SEK.

Lowest
Price Target
484.8 SEK
7% Upside
Average
Price Target
555.7 SEK
23% Upside
Highest
Price Target
613.2 SEK
35% Upside
Xvivo Perfusion AB Competitors:
Price Targets
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
30% Upside
NAN
Nanosonics Ltd
4% Upside
AP4
Riverstone Holdings Ltd
6% Upside
VIMIAN
Vimian Group AB
14% Upside
605369
Zhejiang Gongdong Medical Technology Co Ltd
61% Upside
300981
Zhonghong Pulin Medical Products Co Ltd
13% Downside
STAA
STAAR Surgical Co
78% Upside
HARTA
Hartalega Holdings Bhd
5% Downside

Revenue
Forecast

Revenue Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 22%. The projected CAGR for the next 3 years is 39%.

22%
Past Growth
39%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is -4%. The projected CAGR for the next 3 years is 330%.

-4%
Past Growth
330%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 43%. The projected CAGR for the next 3 years is 52%.

43%
Past Growth
52%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XVIVO's stock price target?
Price Target
555.7 SEK

According to Wall Street analysts, the average 1-year price target for XVIVO is 555.7 SEK with a low forecast of 484.8 SEK and a high forecast of 613.2 SEK.

What is Xvivo Perfusion AB's Revenue forecast?
Projected CAGR
39%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 22%. The projected CAGR for the next 3 years is 39%.

What is Xvivo Perfusion AB's Operating Income forecast?
Projected CAGR
330%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is -4%. The projected CAGR for the next 3 years is 330%.

What is Xvivo Perfusion AB's Net Income forecast?
Projected CAGR
52%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 43%. The projected CAGR for the next 3 years is 52%.

Back to Top